OpenAlex
PricingAboutJobs
Log inGet started
Work

Series of Novel and Highly Potent Cyclic Peptide PCSK9 Inhibitors Derived from an mRNA Display Screen and Optimized via Structure-Based Design

HTML

Year: 2020
Type: article
Source: Journal of Medicinal Chemistry
DOI: 10.1021/acs.jmedchem.0c01084
Authors: Candice Alleyne, Rupesh P. Amin, Bhavana Bhatt, Elisabetta Bianchi, J. Craig Blain, Nicolas Boyer, Danila Branca, Mark W. Embrey, Sookhee N. Ha, Kelli Jette, Douglas G. Johns, Angela D. Kerekes, Kenneth A. Koeplinger, Derek LaPlaca, Nianyu Li, Beth Murphy, Peter Orth, Alonso Ricardo, Scott Salowe, Kathleen Seyb, Aurash Shahripour, Joseph R. Stringer, Yili Sun, Rodger Tracy, Chengwei Wu, Yusheng Xiong, Hyewon Youm, Hratch J. Zokian, Thomas J. Tucker
Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), IRBM
Language: English

Topic: Chemical Synthesis and Analysis
Subfield: Organic Chemistry
Field: Chemistry
Domain: Physical Sciences
Keywords: PCSK9 inhibitors, cyclic peptides, structure-based drug design, hypercholesterolemia, LDL cholesterol, bicyclic peptides, metabolic stability, cardiovascular disease
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W3103359916
FWCI: 3.744
Cites: 31
Cited by: 144
Related to: 10
Parts: 6
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security